Manufacturing News and Research

RSS

Manufacturing is the production of products across all industries, on a large-scale, using machinery.

China BCT to launch 21 new retail pharmacy stores in Guangxi

China BCT Pharmacy Group, Inc., a leading pharmaceutical distributor, retail pharmacy, and manufacturer of pharmaceutical products in Guangxi Province, China, today announced that the Company is in the process of launching 21 new retail pharmacy stores in Guangxi, bringing the total number of "Baicaotang" branded stores to 208.

21 Jul 2011

St. Jude Medical second quarter net sales increase 10% to $1.447 billion

St. Jude Medical, Inc. today reported sales and net earnings for the second quarter ended July 2, 2011.

20 Jul 2011

Two instruments of Thermo Fisher Scientific win 2011 R&D 100 Award

Thermo Fisher Scientific, the world leader in serving science, today announced that two of its instruments are 2011 R&D 100 Award winners: the Thermo Scientific Evolution 200 series UV-Vis spectrophotometer and the Thermo Scientific Dionex ICS-5000 capillary ion chromatography system.

From Thermo Fisher Scientific Inc. 20 Jul 2011

Tyco reaches agreement to acquire Chemguard

Tyco International Ltd. announced today that it has reached an agreement to acquire privately-held Chemguard, Inc., a leading provider of firefighting foam concentrates and equipment, foam systems, services and specialty chemicals. Chemguard will be integrated into Tyco's Fire Protection Products business unit.

20 Jul 2011

Main Street completes $6.5 million new portfolio investment

Main Street Capital Corporation announced today that it has completed a new portfolio investment totaling $6.5 million.

19 Jul 2011

Johnson & Johnson second quarter sales increase 8.3% to $16.6 billion

Johnson & Johnson today announced sales of $16.6 billion for the second quarter of 2011, an increase of 8.3% as compared to the second quarter of 2010.

19 Jul 2011

EPA to expand Cooperative Research And Development Agreement with NanoLogix

NanoLogix, a biotechnology innovator in the rapid detection and identification of live-cell bacteria and microorganisms, announced today the U.S. Environmental Protection Agency (EPA) intends to expand its Cooperative Research And Development Agreement (CRADA) with NanoLogix to include additional water-borne pathogens.

19 Jul 2011

Nano-patterned plastic to advance stem cell research

Scientists have developed a novel plastic surface which overcomes the difficulties associated with growing adult stem cells. Standard surfaces have proved limited for growing large amounts and retaining the stem cells' useful characteristics. This discovery could lead to the creation of stem cell therapies for re-growing bone and tissue, and also for conditions such as arthritis. The study was carried out by Glasgow and Southampton universities.

18 Jul 2011

Two existing clinical stage clients expand development activities with Progenitor Cell Therapy

Progenitor Cell Therapy (PCT), an internationally recognized cell therapy services and development company, and a wholly-owned subsidiary of NeoStem, Inc., an international biopharmaceutical company with operations in the U.S. and China, announced today that two existing clinical stage biopharmaceutical corporate clients have chosen to expand their development activities with PCT.

18 Jul 2011

Cardinal Health opens The Center for the Advancement of Molecular Imaging in Phoenix

Today in Phoenix, Cardinal Health opened The Center for the Advancement of Molecular Imaging – a new, first-of-its-kind collaboration laboratory that will expedite the development of nuclear imaging agents that treat complex diseases like cancer, heart disease and neurological disorders.

18 Jul 2011

Intelsius, American Thermal Instruments enter strategic partnership

Intelsius, a global manufacturer and distributor of environmentally sustainable, temperature-controlled and regulatory-compliant packaging solutions, announces a strategic partnership with American Thermal Instruments (ATI), a leader in temperature monitoring, inspections and asset tracking.

18 Jul 2011

QRxPharma seeks NDA approval for MoxDuo IR

QRxPharma Limited announced today initiation of the New Drug Application (NDA) approval process for MoxDuo IR with the United States Food and Drug Administration (FDA). This NDA submission sets the stage for the regulatory approval process for MoxDuo IR for the treatment of moderate to severe acute pain, a $2.5 billion segment of the $8 billion spent annually on prescription opioids in the US.

18 Jul 2011

Guizhou Provincial Health Department issues 'Revised Plan' for blood collection stations

China Biologic Products, Inc., a leading plasma-based biopharmaceutical company in China, today announced that the Guizhou Provincial Health Department has issued the revised "Plan for Guizhou Provincial Blood Collection Institutional Setting."

16 Jul 2011

Iranian team demonstrates how rapid prototyping can be used in dentistry

Researchers in Iran explain how medical imaging coupled with computer-aided design could be used to create a perfect-fit blueprint for prosthetic dentistry, whether to replace diseased or broken teeth and jaw bone.

15 Jul 2011

Seattle Children's inaugurates new center for cancer research

Today, Seattle Children's Research Institute announced the opening of the Center for Childhood Cancer Research.

15 Jul 2011

NeoStem to acquire Amorcyte

NeoStem, Inc., an international biopharmaceutical company, announced the signing of a definitive merger agreement whereby NeoStem will acquire Amorcyte, Inc., a development stage cell therapy company focusing on novel treatments for cardiovascular disease.

15 Jul 2011

DVS Sciences completes $14.6M series A financing

The Ontario Institute for Cancer Research (OICR) and DVS Sciences Inc., today announced that DVS Sciences has completed a $14.6 million series A financing.

14 Jul 2011

New system for optimizing eyesight

With research and development assistance from the Georgia Tech Research Institute (GTRI) and seed funding from the Georgia Research Alliance (GRA), an Atlanta-based company is developing what it hopes will be the next-generation instrument for optimizing eyesight for the hundreds of millions of people who wear glasses or contacts - or who are candidates for corrective surgery.

14 Jul 2011

Cornell grants ChromaDex worldwide rights to novel manufacturing process for nicotinamide riboside

ChromaDex Corp. today announced that Cornell University has granted the natural products company ChromaDex exclusive worldwide rights to a novel manufacturing process for nicotinamide riboside (NR).

14 Jul 2011

PharmAthene demonstrates 36 month stability of rPA anthrax vaccine program candidate

PharmAthene, Inc. announced today that it has achieved an important program milestone in its recombinant protective antigen (rPA) anthrax vaccine program and demonstrated 36 month stability of its rPA drug product candidate previously produced at Avecia Biologics Laboratories in the United Kingdom. The stability data were prepared utilizing a variety of analytical methods and a well characterized mouse challenge potency assay.

14 Jul 2011